Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 11, 2022
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2022  
Document Transition Report false  
Entity File Number 001-39811  
Entity Registrant Name Virios Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 85-4314201  
Entity Address, Address Line One 44 Milton Avenue  
Entity Address, City or Town Alpharetta  
Entity Address State Or Province GA  
Entity Address, Postal Zip Code 30009  
City Area Code 866  
Local Phone Number 620-8655  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol VIRI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   18,330,390
Entity Central Index Key 0001818844  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Amendment Flag false